Evidence map›Paper›PMID 29995265›Full record

ArticleMolecular and cellular biochemistry2019

Anti-neuroinflammatory effects of galangin in LPS-stimulated BV-2 microglia through regulation of IL-1β production and the NF-κB signaling pathways.

Mi Eun Kim, Pu Reum Park, Ju Yong Na, Inae Jung, Jun Hwi Cho, Jun Sik Lee

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Current issues in molecular biology · 2022
    Article
  7. Article
  8. Hydroxysafflor Yellow A Inhibits AβNeurochemical research · 2022
    Article
  9. Article
  10. Article
  11. Native Endophytes ofFrontiers in microbiology · 2022
    Article
  12. Anti-Inflammatory Property of the Essential Oil fromMolecules (Basel, Switzerland) · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mi Eun KimDepartment of Life Science, BK21-plus Research Team for Bioactive Control Technology, College of Natural Sciences, Chosun University, Dong-gu, Gwangju, 61452, Republic of Korea.
Pu Reum ParkDepartment of Life Science, BK21-plus Research Team for Bioactive Control Technology, College of Natural Sciences, Chosun University, Dong-gu, Gwangju, 61452, Republic of Korea.
Ju Yong NaDepartment of Life Science, BK21-plus Research Team for Bioactive Control Technology, College of Natural Sciences, Chosun University, Dong-gu, Gwangju, 61452, Republic of Korea.
Inae JungDepartment of Life Science, BK21-plus Research Team for Bioactive Control Technology, College of Natural Sciences, Chosun University, Dong-gu, Gwangju, 61452, Republic of Korea.
Jun Hwi ChoDepartment of Life Science, BK21-plus Research Team for Bioactive Control Technology, College of Natural Sciences, Chosun University, Dong-gu, Gwangju, 61452, Republic of Korea.
Jun Sik LeeDepartment of Life Science, BK21-plus Research Team for Bioactive Control Technology, College of Natural Sciences, Chosun University, Dong-gu, Gwangju, 61452, Republic of Korea. junsiklee@chosun.ac.kr.ORCID http://orcid.org/0000-0003-1051-581X
Chosun University · KR

Funding

Chosun University K206212009
6 · The paper itself

Abstract

Neuroinflammation resulting from microglial activation is involved in the pathogenesis of neurodegenerative diseases, including Parkinson's diseases. Microglial activation plays an important role in neuroinflammation and contributes to several neurological disorders. Hence, inhibition of both microglial activation and the generation of pro-inflammatory cytokines may lead to an effective treatment for neurodegenerative diseases. In the present study, the anti-neuroinflammatory effects of galangin were investigated in lipopolysaccharide (LPS)-stimulated BV-2 microglial cells. Galangin significantly decreased the generation of nitric oxide, interleukin-1β, and inducible nitric oxide synthase in LPS-stimulated BV-2 microglial cells. In addition, galangin inhibited the phosphorylation of p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase 1/2. Furthermore, it was observed that activation of both IκB-α and nuclear factor kappa B (NF-κB) was significantly increased following LPS stimulation, and this effect was suppressed by galangin treatment. In conclusion, galangin displayed an anti-neuroinflammatory activity in LPS-stimulated BV-2 microglial cells. Galangin inhibited LPS-induced neuroinflammation via the MAPK and NF-κB signaling pathways and might act as a natural therapeutic agent for the treatment of various neuroinflammatory conditions.

Indexed as

AnimalsAnti-Inflammatory AgentsCytokinesFlavonoidsGene Expression RegulationInflammationInterleukin-1betaLipopolysaccharidesMiceMicrogliaMutagensNF-KappaB Inhibitor alphaNitric OxidePhosphorylationSignal TransductionAnti-Inflammatory AgentsCytokinesFlavonoidsgalanginInterleukin-1betaLipopolysaccharidesMutagensNF-KappaB Inhibitor alphaNfkbia protein, mouseNitric OxideBV-2 microglial cellsGalanginIL-1β productionNeuroinflammation

Identifiers

PMID29995265
OpenAlexW2845252951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.